DNA
$6.52
Revenue | $33.4Mn |
Net Profits | $-80.75Mn |
Net Profit Margins | -241.8% |
Ginkgo Bioworks Holdings Inc’s revenue fell -23.84% since last year same period to $33.4Mn in the Q4 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -14.01% fall in its revenue since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit jumped 24.91% since last year same period to $-80.75Mn in the Q4 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 0% jump in its net profits since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit margin jumped 1.41% since last year same period to -241.8% in the Q4 2025. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -16.29% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Current Year | -0.07 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a 22.22% jump from last quarter’s estimates.
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.07.
Earning Per Share (EPS) | -1.42 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) jumped 29% since last year same period to -1.42 in the Q4 2025. This indicates that the Ginkgo Bioworks Holdings Inc has generated 29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-06 | -0.08 | -1.68 | -2000% |
2025-11-06 | -0.09 | -1.45 | -1511.11% |
2025-08-07 | -0.1 | -1.1 | -1000% |
2026-02-26 | -0.07 | -1.42 | -1928.57% |